+86-13708084407
  export@pu-kang.com            yasmin@pu-kang.com
 

PRODUCTS

Professionally provide long-acting peptide, Small Molecule Compounds, API and Advanced Excipients, LINKERs, PEGs

ABOUT PUKANG

Manufacturer of long-acting peptide pharmaceuticals for chronic diseases in China.
Chengdu Pukang Biotechnology Co., Ltd was founded in 2008 and it is located in the national cross-strait science and technology industry development park——Cross-Strait Science and Technology Park, Wenjiang District, Chengdu,specializing in the long-term development of peptide drugs for chronic disease. As a manufacturer, it integrates production, sales, research and development. At present, our company has a research and development center of 2400 square meters, and a production workshop of 1000 square meters.
0+
Founded
0+
R & D Center
0+
Production workshop
0+
Production base
TECHNOLOGY
Pukang Bio is a professional manufacturer of long-acting peptide, Small Molecule Compounds, API and Advanced Excipients, LINKERs, PEGs.


GOOD QUALITY,GOOD TECHNOLOGY .

Pukang masters advanced medical technology
Chengdu Pukang has a professional R&D team with rich experience, and innovative ideas, which can meet the various needs of customers from custom synthesis to mass production. Pukang has sufficient resources to provide process development, optimization and scale-up production. The R & D will cooperate with the production to solve the problems encountered in the pilot scale up process. We are more professional, more efficient to provide customers with high quality products.

BUILT FOR LIFE AND HEALTH

——————————————————————————
Polyethylene glycols is used in a wide range of biomedical applications including drug delivery, ADC conjugation, fluorescent labeling & targeted diagnostics, oligonucleotides bioconjugation, surface modification and PEGylation of protein &peptide.

NEWS

Latest technology learnings and upcoming events of Pukang

ADC.png
2021-11-05
Antibody-Drug Conjugates: The Last Decade

AbstractAn armed antibody (antibody-drug conjugate or ADC) is a vectorized chemotherapy, which results from the grafting of a cytotoxic agent onto a monoclonal antibody via a judiciously constructed spacer arm. ADCs have made considerable progress in 10 years. While in 2009 only gemtuzumab ozogamici

View More
企业微信截图_16354300337616.png
2021-10-28
Tirzepatide results superior A1C and body weight reductions compared to insulin glargine in adults with type 2 diabetes

Newly published data show that participants maintained A1C and weight control up to two years in SURPASS-4, the largest and longest SURPASS trial completed to dateNo increased cardiovascular risk identified with tirzepatide; hazard ratio of 0.74 observed for MACE-4 events

View More
PROTAC.jpg
2021-09-29
What are PROTACs and How Do They Treat Diseases?

Around 80% of disease-causing proteins, including key drivers of many cancers and other serious neurological conditions like Alzheimer’s disease, cannot be targeted by currently available therapeutics. These so called “undruggable” proteins lack specific surface areas required for treatments such as

View More

22 SERVICES

Pukang provides you with pharmaceutical services

Pukang can provide one-stop service from customer order to delivery, including the feedback of production progress, various items testing and technical documents support.

Product Testing

Technical Support

Delivery Service

Product Development

After-sales Service

Progress Feedback

About Us
Chengdu Pukang has a professional R&D team with rich experience, and innovative ideas, which can meet the various needs of customers from custom synthesis to mass production.
Contact Us
​​​​​​​​​​​​​​No.288 of North Rongtai Avenue,WenJiang district 611137,Chengdu Sichuan
Province,China.
+86-28-63976226
Copyright © 2021 chengdu Pukang Biological Technology Co., Ltd.  Support By Leadong  Sitemap / Private Policy
Leave a Message
Contact us